We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTF:NASDAQWaton Financial Limited Analysis

Data as of 2026-05-11 - not real-time

$3.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Waton Financial Limited (NASDAQ:WTF) is trading at $3.90, well above its discounted cash‑flow fair value of $1.36, suggesting significant overvaluation. The price‑to‑book ratio sits at 6.79, far higher than typical for financial services, reinforcing the premium pricing. Revenue growth is essentially flat at 0.1 % and the company posts negative gross (‑56 %) and operating margins (‑134 %), indicating a struggling core business. With a trailing EPS of –$0.39 and no dividend, the dividend sustainability flag is clearly false. Technicals show the 20‑day SMA (3.81) above the 50‑day SMA (3.73) and a bullish MACD histogram, while the 200‑day SMA (4.32) remains above current price, pointing to short‑term momentum but long‑term weakness. The RSI of 53 is neutral, and the stock is trading between a support of $3.08 and resistance near $4.49. Volume has been increasing, supporting the recent price gains.
Volatility is extreme at 103 % over the past 30 days and the maximum historical drawdown exceeds 60 %, highlighting substantial price swings. Beta of 1.04 ties the stock closely to market movements, adding market‑related risk. The recent class‑action investigation announced by Rosen Law Firm introduces heightened regulatory and legal risk. Operating cash flow of $1.46 M provides limited cushion against ongoing losses. The company’s capital structure shows a debt‑to‑equity of 6.5, indicating leverage concerns. Given the overvalued market price, weak profitability, and elevated risk factors, the outlook remains challenging. Investors should therefore approach WTF with caution, limiting exposure unless a clear turnaround materializes.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD and rising volume
  • Price above short‑term support level
  • Pending class‑action investigation adds uncertainty

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Market price far exceeds DCF fair value
  • Negative margins and earnings
  • High volatility and large historical drawdown

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Fundamental turnaround unlikely without major operational changes
  • Sustained legal and regulatory risk
  • Structural overvaluation relative to peers

Key Metrics & Analysis

Financial Health

Revenue Growth100.10%
Profit Margin-191.20%
ROE-102.73%
ROA-42.78%
Debt/Equity6.52
P/B Ratio6.8
Op. Cash Flow$1.5M
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI53.9
Support$3.08
Resistance$4.49
MA 20$3.81
MA 50$3.73
MA 200$4.32
MACDBullish
VolumeIncreasing
Fear & Greed Index90.73

Valuation

Fair Value$1.36
GradeOvervalued
TypeValue

Risk Assessment

Beta1.04
Volatility103.17%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.